US · Healthcare · Medical Care Facilities
EPS came in at 1.14 against a street estimate of 0.83 — a beat of 37.3%.
Analysts rate agilon health Inc a hold (4 buy, 14 hold, 2 sell out of 20) with an average price target of $78.14.
| Fund | Stake |
|---|---|
| Clayton Dubilier & Rice LLC | 23.98% |
| Morgan Stanley - Brokerage Accounts | 0.50% |
| North Peak Capital Management, LLC | 0.37% |
| The Goldman Sachs Group Inc | 0.25% |
| AQR Capital Management LLC | 0.23% |
| BlackRock Inc | 0.21% |
| D. E. Shaw & Co LP | 0.18% |
| Vanguard Capital Management, LLC | 0.13% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 | 2026-07-22 |
| Shareholder vote results · Q2 2026 | 2026-06-03 |
| Quarterly report · Q1 2026 | 2026-05-06 |
| Results announced · Q2 2026 | 2026-05-06 |
| Board / officer change · Q2 2026 | 2026-04-27 |
| Proxy statement · Q2 2026 | 2026-04-22 |
| Annual report FY2025 | 2026-02-25 |
| Proxy statement · Q1 2026 | 2026-02-18 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for agilon health Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.